MASI vs. ITGR, CNMD, INMD, TMDX, LIVN, NBIX, RDY, JAZZ, RGEN, and OSH
Should you be buying Masimo stock or one of its competitors? The main competitors of Masimo include Integer (ITGR), CONMED (CNMD), InMode (INMD), TransMedics Group (TMDX), LivaNova (LIVN), Neurocrine Biosciences (NBIX), Dr. Reddy's Laboratories (RDY), Jazz Pharmaceuticals (JAZZ), Repligen (RGEN), and Oak Street Health (OSH). These companies are all part of the "medical" sector.
Masimo vs.
Integer (NYSE:ITGR) and Masimo (NASDAQ:MASI) are both mid-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, valuation, dividends, profitability and community ranking.
Masimo has higher revenue and earnings than Integer. Integer is trading at a lower price-to-earnings ratio than Masimo, indicating that it is currently the more affordable of the two stocks.
In the previous week, Masimo had 10 more articles in the media than Integer. MarketBeat recorded 14 mentions for Masimo and 4 mentions for Integer. Masimo's average media sentiment score of 0.54 beat Integer's score of 0.27 indicating that Masimo is being referred to more favorably in the news media.
98.4% of Integer shares are owned by institutional investors. Comparatively, 87.7% of Masimo shares are owned by institutional investors. 2.0% of Integer shares are owned by insiders. Comparatively, 9.7% of Masimo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Integer currently has a consensus target price of $87.00, indicating a potential upside of 13.47%. Masimo has a consensus target price of $182.00, indicating a potential upside of 5.28%. Given Integer's stronger consensus rating and higher probable upside, analysts clearly believe Integer is more favorable than Masimo.
Masimo received 80 more outperform votes than Integer when rated by MarketBeat users. Likewise, 66.37% of users gave Masimo an outperform vote while only 64.10% of users gave Integer an outperform vote.
Integer has a beta of 1.11, meaning that its stock price is 11% more volatile than the S&P 500. Comparatively, Masimo has a beta of 0.86, meaning that its stock price is 14% less volatile than the S&P 500.
Masimo has a net margin of 7.06% compared to Integer's net margin of 4.82%. Masimo's return on equity of 18.84% beat Integer's return on equity.
Summary
Masimo beats Integer on 14 of the 18 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding MASI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
